Article
Why early, big-picture planning is key to execution across the CGT lifecycle
For cell and gene therapies, the solution for the challenge you have today may create another challenge tomorrow. Early decisions around clinical development, manufacturing, regulatory strategy, and evidence generation can affect commercialization years later. See how successful manufacturers can take a cross-functional approach across the lifecycle to prevent obstacles before they occur.
Download to learn more
Connect with our cell and gene experts
Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
